Diovan HCT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Valsartan; Hydrochlorothiazide.
| Product ID | 0078-0315_0fa1a408-909e-4098-96ac-2bef1bd97298 | 
| NDC | 0078-0315 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Diovan HCT | 
| Generic Name | Valsartan And Hydrochlorothiazide | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 1998-03-06 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020818 | 
| Labeler Name | Novartis Pharmaceuticals Corporation | 
| Substance Name | VALSARTAN; HYDROCHLOROTHIAZIDE | 
| Active Ingredient Strength | 160 mg/1; mg/1 | 
| Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 1998-03-06 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020818 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 1998-03-06 | 
| Marketing End Date | 2017-05-31 | 
| Marketing Category | NDA | 
| Application Number | NDA020818 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 1998-03-06 | 
| Marketing End Date | 2015-08-10 | 
| Marketing Category | NDA | 
| Application Number | NDA020818 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2011-01-25 | 
| Marketing End Date | 2015-08-10 | 
| Marketing Category | NDA | 
| Application Number | NDA020818 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2010-04-06 | 
| Marketing Category | NDA | 
| Application Number | NDA020818 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 1998-03-06 | 
| Marketing Category | NDA | 
| Application Number | NDA020818 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-08-29 | 
| Marketing End Date | 2015-08-10 | 
| Ingredient | Strength | 
|---|---|
| VALSARTAN | 160 mg/1 | 
| SPL SET ID: | d76a0419-05ee-437e-884c-65807aea9569 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0078-0314 | Diovan HCT | valsartan and hydrochlorothiazide | 
| 0078-0315 | Diovan HCT | valsartan and hydrochlorothiazide | 
| 0078-0383 | Diovan HCT | valsartan and hydrochlorothiazide | 
| 0078-0471 | Diovan HCT | valsartan and hydrochlorothiazide | 
| 0078-0472 | Diovan HCT | valsartan and hydrochlorothiazide | 
| 68258-6056 | Diovan HCT | Diovan HCT | 
| 68258-6053 | Diovan HCT | Diovan HCT | 
| 68258-6972 | Diovan HCT | Diovan HCT | 
| 68258-6973 | Diovan HCT | Diovan HCT | 
| 55289-820 | Diovan HCT | Diovan HCT | 
| 55289-838 | Diovan HCT | Diovan HCT | 
| 0378-6321 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide | 
| 0378-6322 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide | 
| 0378-6323 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  DIOVAN HCT  75189097  2182834 Live/Registered | NOVARTIS CORPORATION 1996-10-28 |